Cargando…

A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the USA, affecting predominantly older adults. CLL is characterized by low physical fitness, reduced immunity, and increased risk of secondary malignancies and infections. One approach to improving CLL patients’ physical fitness and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacDonald, Grace, Sitlinger, Andrea, Deal, Michael A., Hanson, Erik D., Ferraro, Stephanie, Pieper, Carl F., Weinberg, J. Brice, Brander, Danielle M., Bartlett, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633014/ https://www.ncbi.nlm.nih.gov/pubmed/34848750 http://dx.doi.org/10.1038/s41598-021-02352-6

Ejemplares similares

High-Intensity Interval Training in Older Adults With Treatment Naive Chronic Lymphocytic Leukemia
por: Bartlett, David, et al.
Publicado: (2021)

Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia
por: Sitlinger, Andrea, et al.
Publicado: (2022)

Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)
por: Sitlinger, Andrea, et al.
Publicado: (2021)

Clinical and Biological Relevance of Genomic Heterogeneity in Chronic Lymphocytic Leukemia
por: Friedman, Daphne R., et al.
Publicado: (2013)

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
por: Cerquozzi, Sonia, et al.
Publicado: (2015)

Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia
por: Bennett, Rory, et al.
Publicado: (2023)

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia
por: Eyre, Toby A., et al.
Publicado: (2020)

Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma
por: Shibayama, Hirohiko, et al.
Publicado: (2019)

A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy
por: Eichenberger, Emily M., et al.
Publicado: (2019)

Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia
por: Ooi, Melissa G, et al.
Publicado: (2009)

Disseminated cryptococcal infection in a patient with treatment-naïve chronic lymphocytic leukemia (CLL)
por: Suleman, Adam, et al.
Publicado: (2019)

Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
por: Paneesha, S., et al.
Publicado: (2020)

Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion
por: Tam, Constantine S., et al.
Publicado: (2020)

Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals
por: Blanco-Heredia, Juan, et al.
Publicado: (2016)

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
por: Kleinstern, Geffen, et al.
Publicado: (2021)

Correction: Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals
por: Blanco-Heredia, Juan, et al.
Publicado: (2016)

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY
por: Munir, Talha, et al.
Publicado: (2023)

Changes in mitochondrial function and mitochondria associated protein expression in response to 2-weeks of high intensity interval training
por: Vincent, Grace, et al.
Publicado: (2015)

Herpes Simplex Necrotic Lymphadenitis Masquerading as Richter’s Transformation in Treatment-Naive Patients With Chronic Lymphocytic Leukemia
por: Hodgson, Yan Amber, et al.
Publicado: (2019)

Progressive Multifocal Leukoencephalopathy in a Chemotherapy-Naive Patient With Chronic Lymphocytic Leukemia: A Case Report
por: Jancar, Nina, et al.
Publicado: (2022)

Hormone naïve prostate cancer: predicting and maximizing response intervals
por: Moul, Judd W
Publicado: (2015)

PB1941: MIND-BODY INTERVENTION PROLONGS LYMPHOCYTE DOUBLING TIME AND TREATMENT-FREE SURVIVAL IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
por: Shapira, Shirley, et al.
Publicado: (2023)

Effect of High-Intensity Interval Training on Rheumatoid Arthritis CD4+ T Cell Oxidative Metabolism
por: Andonian, Brian, et al.
Publicado: (2021)

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients
por: Colom-Fernández, Beatriz, et al.
Publicado: (2019)

The Effects of 16 Weeks of Exercise Training on Neutrophil Functions in Breast Cancer Survivors
por: Bartlett, David B., et al.
Publicado: (2021)

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12
por: Autore, Francesco, et al.
Publicado: (2019)

The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia
por: ESATOĞLU, Sinem Nihal, et al.
Publicado: (2021)

Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia
por: Garner, Lauren M., et al.
Publicado: (2021)

A pilot study to assess the feasibility of a remotely monitored high-intensity interval training program prior to allogeneic hematopoietic stem cell transplantation
por: Artese, Ashley L., et al.
Publicado: (2023)

Strategies to Improve Private-Well Water Quality: A North Carolina Perspective
por: MacDonald Gibson, Jacqueline, et al.
Publicado: (2017)

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
por: Hillmen, Peter, et al.
Publicado: (2019)

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
por: Mato, Anthony R., et al.
Publicado: (2018)

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
por: Hoffmann, Jean-Marc, et al.
Publicado: (2018)

Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib
por: Koshiishi, Megumi, et al.
Publicado: (2021)

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
por: Rodrigues, Celso Arrais, et al.
Publicado: (2016)

Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody
por: Winkler, Mark T., et al.
Publicado: (2017)

Naive and memory T cells show distinct pathways of lymphocyte recirculation
Publicado: (1990)

Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients
por: Andrieu, Thibault, et al.
Publicado: (2022)

Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia
por: Huang, Chunfa, et al.
Publicado: (2018)

B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_6q8aujaqvaqp4fq5iid7tt2np8